Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJK6Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,183
Award facts
- Contract value 100% obligated
- $35,183.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $35,183.00 by the Defense Logistics Agency on January 29, 2026, for the supply of Menveo 1 vial (meningococcal vaccine) in the formulation A-C-Y-W-135-diphtheria conjugate at 0.5 milliliters. The award is a firm fixed-price, non-set-aside contract with performance to be completed by January 30, 2026, with work performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products globally to support military healthcare programs.
The Defense Logistics Agency Medical Supply Chain utilizes the Pharmaceutical Prime Vendor contract vehicle to efficiently procure vaccines and medical supplies for military treatment facilities, the Defense Health Agency, and other federal healthcare systems. Amerisourcebergen's established role as a major pharmaceutical distributor with demonstrated capacity to fulfill federal medical procurement requirements at varying order volumes makes it a critical supplier within the DLA's global pharmaceutical support network. This specific delivery order for the meningococcal vaccine represents routine fulfillment of military healthcare immunization needs through the existing prime vendor relationship.
Quick answers
Who was awarded contract SPE2DR26FJK6Y?
SPE2DR26FJK6Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FJK6Y worth?
The government has obligated $35,183 on SPE2DR26FJK6Y.
Is contract SPE2DR26FJK6Y an order under another contract?
Yes. SPE2DR26FJK6Y is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK6Y competed?
The extent of competition for SPE2DR26FJK6Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award